RC-222

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRC-222
Drug Alias NameRC-222
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type II alpha subunit blockers
TargetsSodium channel protein type II alpha subunit
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRogCon Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncRogCon Biosciences
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A